LDL Cholesterol–Lowering Strategy in ASCVD

Watchdoq November 20, 2024
This systematic review and individual patient data meta-analysis investigates the association of an alternative low-density lipoprotein (LDL) strategy with differences in long-term efficacy and safety in patients with atherosclerotic cardiovascular disease (ASCVD) compared with a high-intensity statin strategy.

Read Full Article